Medtronic plc (NYSE: MDT) will release its second-quarter earnings before the market opens on Tuesday, Sept. 1. The Galway, Ireland-based medical technology company is expected to report quarterly earnings per share (EPS) of $1.39, an increase from $1.26 in the year-ago period.

Consensus estimates project quarterly revenue of $9.54 billion, compared to $8.54 billion reported last year. On Aug. 20, the board declared a cash dividend of 72 cents per ordinary share for the second quarter.

Medtronic shares fell 2.2% to close at $89.97 on Thursday.

Analyst Ratings and Price Targets

Several highly accurate analysts have recently revised their outlook for Medtronic:

• Needham analyst Mike Matson maintained a Buy rating and raised the price target from $101 to $114 on Aug. 27, 2026. His accuracy rate is 58%.
• BTIG analyst Ryan Zimmerman maintained a Buy rating with a price target of $91 on Aug. 18, 2026. His accuracy rate is 65%.
• UBS analyst Priya Sachdeva upgraded the stock from Neutral to Buy and raised the price target from $85 to $100 on July 28, 2026. Her accuracy rate is 67%.
• TD Cowen analyst Joshua Jennings maintained a Buy rating but cut the price target from $119 to $100 on July 10, 2026. His accuracy rate is 57%.
• Evercore ISI Group analyst Vijay Kumar maintained an Outperform rating and cut the price target from $106 to $105 on July 6, 2026. His accuracy rate is 64%.

What the Numbers Show

The consensus revenue estimate of $9.54 billion implies a significant growth trajectory from the prior year’s $8.54 billion. Simultaneously, the EPS forecast of $1.39 represents a notable improvement over the previous year’s $1.26, suggesting analysts anticipate margin expansion or efficiency gains alongside top-line growth.

Medtronic plc (NYSE: MDT) approved a cash dividend of $0.72 per ordinary share for the second quarter of fiscal year 2027. The board authorized the payout on August 20, 2026, maintaining the trajectory set by its June 2026 announcement of an annual dividend increase.

The declaration reinforces Medtronic’s status as a constituent of the S&P 500 Dividend Aristocrats index. The company has raised its annual dividend payment for 49 consecutive years, signaling consistent capital return discipline to shareholders.

Dividend Schedule

The dividend is payable on October 16, 2026. Shareholders must be on record at the close of business on September 25, 2026, to receive the distribution.

Corporate Context

Headquartered in Galway, Ireland, Medtronic operates as a global healthcare technology company. Its portfolio addresses 70 health conditions through cardiac devices, surgical robotics, insulin pumps, and patient monitoring systems. The company employs more than 95,000 people across 150 countries.